Drug Profile
Anti-TNF alpha monoclonal antibody - Center of Molecular Immunology
Alternative Names: Monoclonal antibody anti-chimeric TNF alphaLatest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Center of Molecular Immunology
- Class Monoclonal antibodies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Crohn's disease; Rheumatoid arthritis
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Crohn's-disease in Cuba (Parenteral)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in Cuba (Parenteral)
- 22 Sep 2016 Preclinical trials in Crohn's disease in Cuba (Parenteral) before January 2016 (CIMAB pipeline; January 2016)